In re Lipitor Antitrust Litigation (D.N.J.). Michael Patunas was part of a team defending LDG client Ranbaxy Pharmaceuticals in a so-called “pay-for-delay” antitrust case involving the settlement of patent litigation concerning the drug Lipitor®. The district court dismissed all claims against Ranbaxy.
